Alcon (ALC) ROE % Adjusted to Book Value: 2.06% (As of Mar. 2026)


ALC Alcon Inc ALC
71 GF Score
Price $67.93
GF Value $90.79
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon ROE % Adjusted to Book Value?

Alcon ALC +2.74% 71 ROE % Adjusted to Book Value is 2.06% as of Mar. 2026. GuruFocus rates ALC with a GF Score™ of 71/100 and a GF Value™ of $90.79 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Alcon's ROE % for the quarter that ended in Mar. 2026 was 3.42%. Alcon's PB Ratio for the quarter that ended in Mar. 2026 was 1.66. Alcon's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 2.06%.

Alcon ROE % Adjusted to Book Value Related Terms

Alcon ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Alcon's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcon ROE % Adjusted to Book Value Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 1.01 2.58 2.48 2.59

Alcon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 1.62 2.58 2.26 2.06

ALC vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, Alcon's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alcon ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alcon's ROE % Adjusted to Book Value falls into.


ALC
71GF Score
Alcon Inc ALC
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alcon ROE % Adjusted to Book Value Calculation

Alcon's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.50% / 1.74
=2.59%

Alcon's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.42% / 1.66
=2.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 2.06% mean?
Alcon (ALC) has a ROE % Adjusted to Book Value of 2.06% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alcon and its competitors.
Is Alcon's ROE % Adjusted to Book Value too high?
Alcon's current ROE % Adjusted to Book Value is 2.06%. Overall, Alcon has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's ROE % Adjusted to Book Value compare to ISRG and BDX?
Alcon's ROE % Adjusted to Book Value of 2.06% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alcon and its competitors. Alcon's current ROE % Adjusted to Book Value is 2.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is $90.79, compared to a current price of $67.93 — trading 25.2% below its estimated fair value. The current ROE % Adjusted to Book Value is 2.06%. Alcon's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Alcon (ALC), the current ROE % Adjusted to Book Value is 2.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alcon (ALC) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of $67.93 is trading 25.2% below its estimated GF Value™ of $90.79. GuruFocus considers Alcon to be Modestly Undervalued.

Key valuation signals for ALC:

  • ROE % Adjusted to Book Value: 2.06%
  • GF Value™: $90.79 vs. price of $67.93 (25.2% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
71GF Score

Get the complete analysis for ALC

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$67.93
Price
$90.79
GF Value